Abstract
Indolo[3,2-b]quinoline derivatives (1b-i) with a methyl group at each possible position have been synthesized. The 1-methyl (1b) and 9-methyl (1i) derivatives were inactive, but the 3-methyl (1d), 4-methyl (1e), and 6- methyl (1f) derivatives exhibited high treatment/control (T/C) value and cure rates against leukemia P388 in mice. These results indicated that modification of indolo[3,2-b]quinoline derivatives at 3, 4, and 6 positions may be useful approach for lead optimization.
Original language | English |
---|---|
Pages (from-to) | 2096-2099 |
Number of pages | 4 |
Journal | Chemical and Pharmaceutical Bulletin |
Volume | 45 |
Issue number | 12 |
DOIs | |
Publication status | Published - 1997 |
Keywords
- Antitumor activity
- Indolol[3,2-b]quinoline
- Structure-activity relationship
- Synthesis
ASJC Scopus subject areas
- Chemistry(all)
- Drug Discovery